US NIH starts Covid booster study in people with autoimmune disease
Study participants will be followed for a total of 13 months. Preliminary results are expected in November 2021, the statement said
Study participants will be followed for a total of 13 months. Preliminary results are expected in November 2021, the statement said
The lack of the key gene sequences may dent the current probe into the origin of the pandemic by scientists
